American Uranium Ltd (ASX:AMU) has initiated a non-renounceable entitlement issue to raise approximately AUD 2.59 million, primarily to advance exploration and development at its Lo Herma uranium project in Wyoming.
- Non-renounceable 1-for-6 entitlement issue at $0.12 per share
- One free attaching option for every two new shares subscribed
- Funds earmarked mainly for Lo Herma project development and exploration
- Offer excludes shareholders outside Australia, New Zealand, and select Canadian provinces
- Directors intend to fully participate; offer not underwritten
Capital Raise Targets Lo Herma Expansion
American Uranium Ltd (ASX:AMU) is pressing ahead with a $2.59 million entitlement offer, aiming to bolster its flagship Lo Herma ISR uranium project in Wyoming. The company is offering one new share for every six held by eligible shareholders, priced at 12 cents each, accompanied by one free attaching option for every two shares subscribed. These options carry an exercise price of 16 cents and expire in June 2029.
The offer opens on 1 May 2026 and closes on 15 May, with the company reserving the right to extend the closing date. Notably, this entitlement issue is non-renounceable, meaning shareholders cannot trade or transfer their rights, and it is not underwritten, leaving subscription levels uncertain.
Funds to Accelerate Exploration and Development
Proceeds from the offer are earmarked predominantly for advancing development, exploration, and land holding costs at Lo Herma, with approximately 77% of the raised capital allocated to these activities. The remaining funds will cover offer expenses and provide working capital for corporate overheads and administration.
American Uranium recently completed a $2.64 million placement that also targeted Lo Herma, reflecting a concerted capital-raising strategy to accelerate drilling and technical studies ahead of a planned scoping study in the third quarter of 2026. This entitlement offer follows that placement, with the placement participants entitled to participate in the rights issue, reinforcing continuity in funding efforts.
Shareholders should note that failure to take up their entitlement will result in dilution of approximately 14.29%, with potential dilution rising to around 20% if the attaching options are exercised. The total shares on issue will increase from roughly 129.3 million to 150.9 million, and options outstanding will jump from 47.8 million to 83.5 million, subject to shareholder approvals for certain option tranches.
Regulatory and Market Risks Remain Material
The company’s prospectus outlines extensive risk factors, including uranium price volatility, regulatory complexities in the US mining jurisdictions of Utah, Colorado, and Wyoming, and operational hazards inherent in uranium exploration and mining. Environmental regulations and permitting requirements in the US add layers of compliance risk that could affect project timelines and costs.
Further, American Uranium’s exposure to foreign exchange fluctuations between the US dollar and Australian dollar could impact reported financials. Market conditions and investor sentiment toward uranium equities remain unpredictable, adding to the speculative nature of an investment in AMU’s securities.
Directors Bruce Lane, Petar Tomasevic, James Baughman, and Simon Williamson have indicated their intention to fully subscribe for their entitlements, signaling confidence in the capital raising. The lead manager for the offer is CPS Capital Group Pty Ltd, which also managed the recent placement and will receive fees and options as part of its mandate.
This entitlement offer complements the company’s recent capital-raising activities, including the $2.59M entitlement offer announced days earlier, aimed at accelerating drilling and studies at Lo Herma. The combined capital inflows are designed to sustain exploration momentum and position American Uranium for the next phase of project development.
Bottom Line?
Subscription results and shareholder approval for options will be pivotal in determining how swiftly American Uranium can advance its Lo Herma project amid uranium market and regulatory uncertainties.
Questions in the middle?
- Will the entitlement offer achieve full subscription given it is not underwritten?
- How will uranium price fluctuations and US regulatory changes impact project economics?
- What is the timeline for shareholder approval of the new options and their effect on dilution?